Malaria Study identifies new targets for possible vaccines
Malaria is a disease transmitted by mosquitoes that is estimated to affect over 250 million people a year. Some studies suggest the mortality rate to be as high as three million annually in tropical regions of the world, with young children, the elderly and pregnant women being most susceptible to infection and death.
Of the 200 different kinds of malaria, only two are deadly to humans. According to Frech, a vaccine that successfully targets one or more of the genes involved in either transmitting the parasites or helping them to evade the human immune system could save a million lives a year.
Dr. Jack Chen, a molecular biologist from SFU and co-author of the study explains that some of the genes are specifically active during developmental stages within the mosquito, saying “This suggests these genes could play an important role in the mosquito’s transmission of malaria to humans.”
Frech said the study, “Genome Comparison of Human and Non-Human Malaria Parasites Reveals Species Subset-Specific Genes Potentially Linked to Human Disease,” which is published in the Computation Biology journal of the Public Library of Science, “provides researches with a priority list of the parasites potential vulnerabilities.”




sending...